Literature DB >> 22628232

Factor V Leiden, prothrombin 20210G>A, MTHFR 677C>T and 1298A>C, and homocysteinemia in Tunisian blood donors.

Samira Hadhri1, Mohamed Ben Rejab, Hajer Guedria, Lamia Ifa, Noureddine Chatti, Hadef Skouri.   

Abstract

Specific genetic conditions are known to be associated with high risk of venous thromboembolism. This genetic basis varies widely between ethnic groups. We investigated the distribution of four inherited polymorphisms in 113 unselected Tunisian blood donors by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The allele frequencies of Factor V Leiden (FVL), prothrombin 20210G>A, methylenetetrahydrofolate reductase (MTHFR) 677C>T, and MTHFR 1298A>C mutations were 3, 0.9, 30, and 31%, respectively. The MTHFR 677C>T polymorphism was influenced by age. Twenty-nine of the 113 blood donors demonstrated more than one genetic markers. Hyperhomocysteinemia was found in 12 subjects, and it was statistically associated to the MTHFR 677TT genotype. Principal component analysis allowed disclosing the resemblance between Mediterranean populations. Our findings may be helpful for population genetics study, and provide epidemiologic database for further studies in thrombosis field among Tunisians.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628232      PMCID: PMC6807485          DOI: 10.1002/jcla.21506

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  46 in total

1.  Methylenetetrahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma.

Authors:  Georg Mossbock; Martin Weger; Christoph Faschinger; Iris Steinbrugger; Werner Temmel; Otto Schmut; Wilfried Renner; Clemens Hufnagel; Olaf Stanger
Journal:  Mol Vis       Date:  2006-04-17       Impact factor: 2.367

2.  A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).

Authors:  M Cattaneo; M Y Tsai; P Bucciarelli; E Taioli; M L Zighetti; M Bignell; P M Mannucci
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

Review 3.  Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics.

Authors:  F Bauduer; D Lacombe
Journal:  Mol Genet Metab       Date:  2005-09-26       Impact factor: 4.797

4.  Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Authors:  P M Ridker; J P Miletich; C H Hennekens; J E Buring
Journal:  JAMA       Date:  1997 Apr 23-30       Impact factor: 56.272

5.  Prevalence of the methylenetetrahydrofolate reductase 677C > T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factors.

Authors:  M Guillén; D Corella; O Portolés; J I González; F Mulet; C Sáiz
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

6.  Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age.

Authors:  L Todesco; C Angst; P Litynski; F Loehrer; B Fowler; W E Haefeli
Journal:  Eur J Clin Invest       Date:  1999-12       Impact factor: 4.686

7.  Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.

Authors:  M Den Heijer; S Lewington; R Clarke
Journal:  J Thromb Haemost       Date:  2005-02       Impact factor: 5.824

Review 8.  Population genetics of venous thromboembolism. A narrative review.

Authors:  Maurizio Margaglione; Elvira Grandone
Journal:  Thromb Haemost       Date:  2010-10-12       Impact factor: 5.249

9.  Methylenetetrahydrofolate reductase (MTHFR) allele frequencies in Amerindians.

Authors:  M V Monsalve; F M Salzano; J L Rupert; M H Hutz; K Hill; A M Hurtado; P W Hochachka; D V Devine
Journal:  Ann Hum Genet       Date:  2003-07       Impact factor: 1.670

10.  5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.

Authors:  Temitope Keku; Robert Millikan; Kendra Worley; Scott Winkel; Allison Eaton; Lorna Biscocho; Christopher Martin; Robert Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

View more
  2 in total

1.  Cancer-associated thrombosis: clinical presentation and survival.

Authors:  Magid H Amer
Journal:  Cancer Manag Res       Date:  2013-07-26       Impact factor: 3.989

2.  The prevalence of heterozygous F12 mutations in Chinese population and its relevance to incidents of thrombosis.

Authors:  Xi Wu; Qiulan Ding; Xuefeng Wang; Jing Dai; Wenman Wu
Journal:  BMC Med Genet       Date:  2018-03-27       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.